KLOW is an advanced four-peptide regenerative stack combining GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) into a single 80mg vial. It builds on GLOW by adding KPV — a potent anti-inflammatory tripeptide derived from α-MSH — for enhanced inflammation control and gut health support.
Mechanism of action
GHK-Cu drives collagen synthesis and wound healing gene activation. KPV (Lysine-Proline-Valine) downregulates pro-inflammatory cytokines while supporting gut epithelial integrity. BPC-157 modulates nitric oxide and growth factor pathways for tissue healing. TB-500 promotes cellular migration and muscle fiber repair. Four complementary mechanisms working simultaneously.
Research context
KLOW combines the tissue repair capabilities of GLOW with the anti-inflammatory and gut-protective properties of KPV. Research on the individual components supports applications in chronic inflammation, injury recovery, gut dysfunction, and skin regeneration.
⚠ For research purposes only. Not approved for human use by the FDA. Not for human consumption.
Research dosing reference
Starting dose
1–2 mg
Frequency
Once or twice daily
Max studied
2 mg / dose
Route
Subcutaneous
Protocol notes
1–2 mg subcutaneously once or twice daily. Some protocols suggest twice daily for the first 2 weeks then reduce to once daily. Typical research cycle: 8–12 weeks on, 4 weeks off.
Commonly observed side effects
Generally well tolerated across all four components at standard doses. Occasional mild injection site irritation. KPV has a strong safety profile with no significant adverse effects in research literature.
⚠ Dosing data sourced from published clinical literature. For research reference only.
Reconstitution protocol
01
Draw 2 mL of bacteriostatic water into a clean syringe.
02
Insert needle through stopper angled toward the glass wall.
03
Slowly push water down the side of the vial.
04
Swirl gently 30–60 seconds. Solution may have a slight blue-green tint from GHK-Cu — this is normal.
05
Label with reconstitution date and refrigerate immediately.
Bacteriostatic water volume
2 mL bacteriostatic water per 80 mg vial
Dose calculation referenceAt 80 mg in 2 mL: each 0.1 mL = 4 mg total blend · GHK-Cu: ~2.5mg · KPV: ~0.5mg · BPC-157: ~0.5mg · TB-500: ~0.5mg per 0.1mL
⚠ Always use bacteriostatic water for multi-dose vials. Never shake — always swirl gently.
Dose Calculator
Enter how much bacteriostatic water you added to your 80mg vial and your target dose. The calculator shows exactly how many units to draw on a standard U-100 insulin syringe.
80 mg
Draw to this mark on your syringe
— units
— mL
Concentration: — mg/mL
⚠ For research reference only. Calculations assume a standard U-100 insulin syringe (100 units = 1 mL). Always verify your measurements.
Injection protocol
01
Draw target dose into insulin syringe.
02
Select injection site.
03
Clean with alcohol swab and allow to dry.
04
Pinch skin, insert at 45°, slowly inject.
05
Remove, apply pressure, dispose safely. Log all details.
Recommended needle
29–31 gauge insulin syringe
Injection sites
Abdomen or near area of research interest. Rotate sites each administration.
⚠ Always rotate injection sites. Never reuse syringes. Dispose of sharps properly.
Storage conditions
Unreconstituted
2–8°C refrigerated · Up to 24 months
Reconstituted
2–8°C refrigerated · Use within 28 days
Stability notes
Blue-green tint in reconstituted solution is normal (copper from GHK-Cu). Store refrigerated away from light. Never freeze reconstituted solution.
⚠ Keep away from children. Do not use if solution appears cloudy or contains particulates.
Educational Videos
Step-by-step video guides coming soon. Contact us via WhatsApp to be notified when videos go live.